Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Obesity and Male Infertility. Best Practice & Research Clinical Obstetrics & Gynaecology, vol
AOD9604 targets fat-rich areas and promotes fat breakdown without disturbing the overall metabolic profile
It comprises (1) endogenous lipid transmitters such as endocannabinoids, including anandamide (AEA) and 2-arachidonoylglycerol (2-AG), (2) cannabinoid receptors (CBR), including type 1 (CB1R) and type 2 (CB2R), and (3) related enzymes such as N-acyl phosphatidylethanolamine-hydrolysis phospholipase D (NAPE-PLD), diacylglycerol lipase (DAGL), and degrading enzymes such as fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) (131)
While both drugs are designed to assist in weight loss, they work through different mechanisms and are approved for different primary indications
Label containers with protein estimates
Glucagon receptor activity can increase energy expenditure and influence fat metabolism, although it can also raise glucose, which is why balancing it with GLP1 and GIP activity is important in research design
